Cannabis Pharma Firm Should Pay Back $2.1 Million, SEC Says

Bloomberg Vivera Pharmaceuticals Inc., its CEO, and another company he controlled that have already been found liable for securities fraud over cannabis-derived products should disgorge about $2.1 million, the SEC told a federal court. The CEO should additionally pay a nearly $240,000 civil penalty and be barred from serving as an officer or director for […]